Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin

NCT00669695 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT00669695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00669695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Lead sponsor
University Hospital, Grenoble
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2008
Completion date
February 28, 2013
Enrollment
54 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea syndrome